OWL Europe Virtual Program

Description

Please join us for our upcoming session:

Bridging the Gap Between Clinical and Commercial:
 From Discovery to Commercialisation

This session aims to explore the complex journey of bringing a pharmaceutical asset from the early stages of clinical development through to a successful commercialization. One of the main challenges is that commercial considerations are often not included at the earlier stages of clinical development, leading to critical gaps in knowledge regarding the future market and competitor landscape, level of unmet need, key stakeholders, patient populations in focus, etc.

These knowledge gaps can have severe consequences for companies who plan to commercialise themselves, but also for smaller companies who will be unable to communicate value if their ultimate objective is to secure a partner.  

Ashley Cox will share her insights, experiences and offer her perspectives on topics such as:

• Defining the stages of clinical development and the path to success;
• The importance of commercial considerations in early-stage research and development;
• Why driving stakeholder alignment across organisations matters;
• Blinded example of an opportunity assessment;
• Two case studies of what can (and did) go wrong when commercial considerations weren’t included.

No matter your role—clinical or commercial, big pharma or startup, medical practice or beyond—understanding the journey of new drugs from the lab to the patient is essential. Join us for an insightful webinar with Ashley Cox and gain valuable perspectives on the commercialisation process!

Register Today!

Thank you to our Partners for their continued support of OWL*

*OWL accepts financial support from industry partners. OWL creates promotional content independently, 

without input or development from Industry Partners.